For: | Zeng DW, Dong J, Jiang JJ, Zhu YY, Liu YR. Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase. World J Gastroenterol 2016; 22(43): 9586-9594 [PMID: 27920479 DOI: 10.3748/wjg.v22.i43.9586] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i43/9586.htm |
Number | Citing Articles |
1 |
Mingrong Ou, Weiming Zhang, Wen Zhang, Jianmin Guo, Rui Huang, Jian Wang, Jiacheng Liu, Juan Xia, Chao Wu, Yijia Zhu, Yuxin Chen. Soluble Programmed Cell Death 1 Protein Is a Promising Biomarker to Predict Severe Liver Inflammation in Chronic Hepatitis B Patients. ACS Omega 2024; 9(14): 16716 doi: 10.1021/acsomega.4c00780
|
2 |
Na-Ling Kang, Jie-Min Zhang, Yu-Rui Liu, Su Lin, Jing Dong, Jia-Ji Jiang, Yue-Yong Zhu, Da-Wu Zeng. Novel predictive models using serum ceruloplasmin levels for hepatic steatosis in patients with chronic hepatitis B infection. Clinics and Research in Hepatology and Gastroenterology 2020; 44(1): 57 doi: 10.1016/j.clinre.2019.04.001
|
3 |
Vitalij А. Datsko, Larisa Ya. Fedoniuk, Yana I. Ivankiv, Khristina I. Kurylo, Аlina S. Volska, Sergij L. Malanchuk, Оleksandra М. Oleshchuk. EXPERIMENTAL CIRRHOSIS: LIVER MORPHOLOGY AND FUNCTION. Wiadomości Lekarskie 2020; 73(5): 947 doi: 10.36740/WLek202005120
|
4 |
Salim Neşelioğlu, Esra Fırat Oğuz, Özcan Erel. Development of a New Colorimetric, Kinetic and Automated Ceruloplasmin Ferroxidase Activity Measurement Method. Antioxidants 2022; 11(11): 2187 doi: 10.3390/antiox11112187
|
5 |
Krishna Sumanth Nallagangula, Shashidhar Kurpad Nagaraj, Lakshmaiah Venkataswamy, Muninarayana Chandrappa. Liver Fibrosis: A Compilation on the Biomarkers Status and Their Significance During Disease Progression. Future Science OA 2018; 4(1) doi: 10.4155/fsoa-2017-0083
|
6 |
Mohammed Hussein Habeeb, Mufeed Jalil Ewadh, Mazen Jaafer Mousa. Ceruloplasmin Activity and Ferritin in Patients with Chronic Liver Disease. Medical Journal of Babylon 2021; 18(3): 257 doi: 10.4103/MJBL.MJBL_32_21
|
7 |
Na-Ling Kang, Jie-Min Zhang, Meng-Xin Lin, Xu-Dong Chen, Zu-Xiong Huang, Yue-Yong Zhu, Yu-Rui Liu, Da-Wu Zeng. Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients. World Journal of Gastroenterology 2020; 26(27): 3948 doi: 10.3748/wjg.v26.i27.3948
|
8 |
Minhui Dong, Jingwen Wu, Xueping Yu, Jing Li, Sisi Yang, Xun Qi, Richeng Mao, Yongmei Zhang, Jie Yu, Haoxiang Zhu, Feifei Yang, Yanli Qin, Jiming Zhang. Validation and comparison of seventeen noninvasive models for evaluating liver fibrosis in Chinese hepatitis B patients. Liver International 2018; 38(9): 1562 doi: 10.1111/liv.13688
|
9 |
Takashi Himoto, Tsutomu Masaki. Current Trends of Essential Trace Elements in Patients with Chronic Liver Diseases. Nutrients 2020; 12(7): 2084 doi: 10.3390/nu12072084
|
10 |
J. Cao, X. Qi, N. Wang, Y. Chen, B. Xie, C. Ma, Z. Chen, W. Xiong. Ceruloplasmin regulating fibrosis in orbital fibroblasts provides a novel therapeutic target for Graves’ orbitopathy. Journal of Endocrinological Investigation 2023; 46(10): 2005 doi: 10.1007/s40618-023-02033-3
|
11 |
Na-Ling Kang, Jie-Min Zhang, Meng-Xin Lin, Xu-Dong Chen, Zu-Xiong Huang, Yue-Yong Zhu, Yu-Rui Liu, Da-Wu Zeng. Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients. World Journal of Gastroenterology 2020; 26(27): 3952-3962 doi: 10.3748/wjg.v26.i27.3952
|
12 |
Maria Tampaki, Nikolaos K. Gatselis, Spyridon Savvanis, Emmanouil Koullias, Asterios Saitis, Stella Gabeta, Melanie Deutsch, Emmanouil Manesis, Georgios N. Dalekos, John Koskinas. Wilson disease: 30-year data on epidemiology, clinical presentation, treatment modalities and disease outcomes from two tertiary Greek centers. European Journal of Gastroenterology & Hepatology 2020; 32(12): 1545 doi: 10.1097/MEG.0000000000001670
|